showed a trendp = 0.060
Patients with composite endpoints had significantly impaired exercise tolerance (6MWD in m, 409 ± 87 vs 465 ± 88, p = 0.031) and showed a trend toward more advanced WHO class symptoms (class I/II, 11 [55.0] vs 31 [83.8], p = 0.060).